KMDA FY 2022 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$129M+24.8% YoY

Gross Profit

$47M36.1% margin

Operating Income

$5M3.5% margin

Net Income

-$2M-1.8% margin

EPS (Diluted)

$-0.05

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$25M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$322M

Total Liabilities

$146M

Stockholders' Equity

$176M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$129M	$104M	+24.8%
Gross Profit	$47M	$30M	+54.0%
Operating Income	$5M	-$696,000	+751.1%
Net Income	-$2M	-$2M	-4.1%